Afficher la couverture 'Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator | Azria, David' en grand format
/5

0 avis

Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator

Archive ouverte

Azria, David | Brengues, Muriel | Gourgou, Sophie | Bourgier, Céline

Edité par CCSD ; Frontiers Media -

International audience. While adjuvant treatments of early breast cancers (BCs) had significantly improved patients' overall survival, some of them will still develop locoregional relapses and/or severe late radio-induced toxicities. Here, we propose to review how to personalize locoregional treatment by identifying patients at high and low risk of locoregional relapse, patients at risk of late radio-induced side effects. We will, therefore, discuss how to enhance BC radiosensitivity. Finally, we will address how personalized radiotherapy could be implemented in prospective clinical trials.

Suggestions

Du même auteur

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

Archive ouverte | Lacombe, Jérôme | CCSD

International audience. Background: Biomarkers for predicting late normal tissue toxicity to radiotherapy are necessary to personalize treatments and to optimize clinical benefit. Many radiogenomic studies have been...

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial

Archive ouverte | Bourgier, Céline | CCSD

International audience. Background:To evaluate risk of severe breast fibrosis occurrence in patients treated by breast-conserving surgery, adjuvant radiotherapy and hormonotherapy (HT) according to individual radios...

In Regard to Pereira et al

Archive ouverte | Azria, David | CCSD

International audience

Chargement des enrichissements...